Latest: FDA Approves New Biosimilar for Oncology Treatment

Preventive Neurology: A Game-Changer for Alzheimer’s and Parkinson’s

0 Mins
Hundreds of millions of people worldwide live with a high risk of developing Alzheimer’s Disease (AD). They display no cognitive symptoms but harbor insidious genetic markers of AD-related brain changes. Simon Nicholls was one of these people. After testing positive for two copies of the ApoE4 gene and concerning blood-based biomarkers for AD, Simon wanted to take control ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago